Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BTCCUEUR

(BTCCUEUR)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/15/20245:44PMBusiness WireFinance of America Announces Expected Effective Date of July 25, 2024 for Reverse Stock SplitNYSE:FOAFinance of America Companies Inc
07/15/20245:43PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:GMGeneral Motors Company
07/15/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVAVAeroVironment Inc
07/15/20245:43PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:CHHChoice Hotels International Inc
07/15/20245:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HBIHanesbrands Inc
07/15/20245:42PMBusiness WireWestlake implementiert NachfolgeplanNYSE:WLKWestlake Corporation
07/15/20245:41PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MESAMesa Air Group Inc
07/15/20245:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:LSFLaird Superfood Inc
07/15/20245:41PMBusiness WireWestlake met en Ĺ“uvre son plan successoralNYSE:WLKWestlake Corporation
07/15/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVAVAeroVironment Inc
07/15/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPRNPrinceton Bancorp Inc
07/15/20245:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ASGNASGN Inc
07/15/20245:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVAVAeroVironment Inc
07/15/20245:38PMPR Newswire (US)M.D.C. Holdings, Inc. Announces Consent Solicitations with Respect to its Outstanding Notes
07/15/20245:36PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MESAMesa Air Group Inc
07/15/20245:35PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MESAMesa Air Group Inc
07/15/20245:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:KMXCarMax Group
07/15/20245:33PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:ASXCAsensus Surgical Inc
07/15/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
07/15/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
07/15/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
07/15/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
07/15/20245:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AZZAZZ Inc
07/15/20245:31PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MESAMesa Air Group Inc
07/15/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SOUNSoundHound AI Inc
07/15/20245:31PMBusiness WireVoya Equity Closed End Funds Declare DistributionsNYSE:IHDVoya Emerging Markets High Income Dividend Equity Fund
07/15/20245:31PMBusiness WireVoya Equity Closed End Funds Declare DistributionsNYSE:IDEVoya Infrastructure Industrials and Materials Fund
07/15/20245:31PMPR Newswire (US)SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight
07/15/20245:31PMBusiness WireVoya Equity Closed End Funds Declare DistributionsNYSE:IAEVoya Asia Pacific High Dividend Equity Income Fund
07/15/20245:31PMPR Newswire (US)SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight